搜索临床试验以：CYT-0851 与卡培他滨联用
总计466个结果
-
Cyteir Therapeutics, Inc.主动，不招人软组织肉瘤 | 滤泡性淋巴瘤 | 乳腺癌 | 头颈癌 | 小细胞肺癌 | 多发性骨髓瘤 | 胰腺癌 | 卵巢癌 | 套细胞淋巴瘤 | 头颈部鳞状细胞癌 | 三阴性乳腺癌 | DLBCL | 非霍奇金淋巴瘤 | 恶性肿瘤 | 慢性淋巴细胞白血病美国
-
Norwegian Breast Cancer Group完全的
-
Qingdao Zhixin Health Technology Co., Ltd.The Affiliated Hospital of Qingdao University未知
-
Jiangsu HengRui Medicine Co., Ltd.招聘中先前接受过曲妥珠单抗和紫杉烷治疗的 HER2 阳性、不可切除和/或转移性乳腺癌受试者中国
-
Heidelberg Pharma AGUnited States Department of Defense完全的
-
Hunan Province Tumor Hospital尚未招聘
-
Hunan Province Tumor Hospital尚未招聘
-
Second Affiliated Hospital of Nanchang University招聘中
-
West China HospitalSichuan Provincial People's Hospital; The First People's Hospital of Ziyang; Chengdu City No.2... 和其他合作者尚未招聘
-
Arvinas Androgen Receptor, Inc.主动，不招人
-
Sun Yat-sen University完全的
-
Ivoclar Vivadent AG招聘中
-
Atrial Fibrillation NetworkDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Preventicus GmbH; Corsano/ MMT; Getemed Medizin-...完全的
-
CStone PharmaceuticalsBlueprint Medicines Corporation完全的
-
Association of Dutch Burn CentresSeventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit, Zürich完全的
-
Association of Dutch Burn CentresSeventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit, Zürich完全的
-
Jiangsu Yahong Meditech Co., Ltd aka Asieris招聘中
-
Leiden University Medical Center招聘中
-
Cytos Biotechnology AG完全的